Assessment of FDG retention differences between the FDG-avid benign pulmonary lesion and primary lung cancer using dual-time-point FDG-PET imaging
Authors:
- 17 February 2013
- journal article
- research article
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 27 (4) , 392-399
Abstract
The aim of this study was to clarify FDG retention differences between FDG-avid benign pulmonary lesions (BPLs) and primary lung cancers (PLCs), and between tuberculous and non-tuberculous BPLs using dual-time-point FDG-PET imaging. Thirty-four BPLs and 47 PLCs with a maximal standardized uptake value (SUVmax) >2.5 and a maximal axial diameter >10 mm were enrolled. We compared the retention index (RI) among different types of lesions, and evaluated the relationship between RI and SUVmax at 1 h (SUV1). Glucose transporter-1 (Glut-1) and hexokinase (HK)-2 expression was assessed in eight non-tuberculous BPLs. BPLs and PLCs showed similar high RIs (mean ± SD 33.6 ± 22.6 and 32.5 ± 23.7, respectively; p = 0.95). In BPLs, both tuberculous and non-tuberculous lesions showed high RIs (39.1 ± 25.8 and 30.3 ± 20.3, respectively; p = 0.43). However, BPLs and PLCs exhibited a different relationship between RI and SUV1. BPLs tended to show lower RIs with higher SUV1s, and a mild negative correlation, whereas PLCs showed persistent high RIs and no significant correlation. Glut-1 and HK-2 expression was found in 75 and 12.5 % of non-tuberculous BPLs, respectively. FDG-avid BPLs could show high RIs regardless of their being tuberculous and non-tuberculous lesions, and no significant difference with PLC RIs was found. FDG-avid BPLs and PLCs showed different relationships between RI and SUV1, and it seemed to be related with different mechanisms of high FDG retention. However, the mechanisms of high FDG retention in FDG-avid BPLs remain unclear, and this matter requires further investigation.Keywords
This publication has 19 references indexed in Scilit:
- Correlation Between 18F-FDG Uptake on PET and Molecular Biology in Metastatic Pulmonary TumorsJournal of Nuclear Medicine, 2011
- Biologic correlates of 18F-FDG uptake on PET in pulmonary pleomorphic carcinomaLung Cancer, 2011
- Biological Factors, Tumor Growth Kinetics, and Survival After Metastasectomy for Pulmonary MelanomaAnnals of Surgical Oncology, 2009
- Assessment of dual-time-point 18F-FDG-PET imaging for pulmonary lesionsNuclear Medicine Communications, 2009
- Dual-Phase 18F-FDG PET in the Diagnosis of Pulmonary Nodules with an Initial Standard Uptake Value Less Than 2.5American Journal of Roentgenology, 2008
- Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lungLung Cancer, 2008
- Sensitivity of FDG PET, GLUT1 expression and proliferative index in bronchioloalveolar lung cancerNuclear Medicine Communications, 2007
- Dual-Time Point FDG PET Imaging in the Evaluation of Pulmonary Nodules With Minimally Increased Metabolic ActivityClinical Nuclear Medicine, 2007
- Computed tomography (CT) and positron emission tomography with [18F]fluoro-2-deoxy-d-glucose (FDG-PET) images of pulmonary cryptococcosis mimicking lung cancerEuropean Journal of Cardio-Thoracic Surgery, 2006
- Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)The Journal of Thoracic and Cardiovascular Surgery, 1995